AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/21/2026

1. RTX
2. BA
3. ZION
4. INTC
5. DPZ
6. MGY
7. WRB
8. RYAAY
9. RYA:ID
10. ORCL

Go back to AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Amgen Inc (NASDAQ: AMGN) Delayed: 366.40 +2.23 (0.61%)
Previous Close $364.17    52 Week High $176.85 
Open $365.09    52 Week Low $133.64 
Day High $368.91    P/E 55.18 
Day Low $362.14    EPS $6.64 
Volume 437,621